Ticlopidine-induced neutropenia mimicking sepsis early after intracoronary stent placement

被引：2
|
作者：
Ochoa, AB
Wolfe, M
Lewis, P
Lenihan, DJ [1 ]
机构：
[1] Wright Patterson Med Ctr, Div Cardiol, SGOMC, Wright Patterson AFB, OH 45433 USA
[2] Wright Patterson Med Ctr, Dept Internal Med, Wright Patterson AFB, OH 45433 USA
来源：
CLINICAL CARDIOLOGY | 1998年 / 21卷 / 04期
关键词：
ticlopidine; sepsis; neutropenia; intracoronary stent;
D O I：
10.1002/clc.4960210417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a case of ticlopidine-induced profound neutropenia early in the course of therapy, which was manifest as a febrile systemic illness mimicking sepsis. This clinical presentation was potentially indicative of a contaminated intracoronary stent. The patient's signs and symptoms of illness promptly resolved with removal of ticlopidine, and no infection was documented. Review of indications for ticlopidine use, potential adverse effects, and monitoring recommendations are discussed.
引用
收藏
页码：304 / 307
页数：4
相关论文
共 50 条
  • [21] Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population
    Taniuchi, M
    Kurz, HI
    Lasala, JM
    CIRCULATION, 2001, 104 (05) : 539 - 543
  • [22] Can ticlopidine be safely discontinued two weeks after coronary stent placement?
    Berger, PB
    Grill, DE
    Melby, SJ
    Bell, MR
    Holmes, DR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 458A - 458A
  • [23] Two or four-week ticlopidine therapy after coronary stent placement?
    Schuhlen, H
    Kastrati, A
    Hausleiter, J
    Hadamitzky, M
    Pache, J
    Wehinger, A
    Dirschinger, J
    CIRCULATION, 1998, 98 (17) : 572 - 572
  • [24] INTRACORONARY STENT PLACEMENT IN THE RECOVERY PERIOD AFTER ACUTE MYOCARDIAL INFARCTION
    Liu Yin Gao Jing Dazhan QuChest HospitalTian jinChina
    中国介入心脏病学杂志, 1998, (04) : 158 - 158
  • [25] Ticlopidine-induced myelosuppression spontaneously remitted after five years: a possible link with amlodipine coadministration
    Girtovitis, F.
    Ntaios, G.
    Baltatzi, M.
    Kaiafa, G.
    Ioannidis, G.
    Chatzinikolaou, A.
    Hatzitolios, A.
    Papadopoulos, A.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (05) : 342 - 343
  • [26] Comparison of platelet inhibition with clopidogrel versus ticlopidine after coronary stent placement.
    Reilly, JP
    Casterella, PJ
    Gallant, EM
    Hann, B
    Woolway, H
    Teirstein, PS
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 10G - 10G
  • [27] A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
    Ikushima, Ichiro
    Yonenaga, Kazuchika
    Iwakiri, Hironao
    Nagoshi, Hideki
    Kumagai, Haruhito
    Yamashita, Yasuyuki
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2011, 4 : 83 - 89
  • [28] Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent
    Spinler, Sarah A.
    Wilensky, Robert L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (13) : 1432 - 1434
  • [29] Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?
    Gazzaruso, C
    Garzaniti, A
    Falcone, C
    Geroldi, D
    Turpini, C
    Fratino, P
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 87 (01) : 91 - 98
  • [30] SUSTAINED GRANULOCYTE RECOVERY AFTER G-CSF IN A PATIENT WITH TICLOPIDINE-INDUCED SEVERE APLASTIC-ANEMIA
    ARRIBALZAGA, K
    GARCIASUAREZ, J
    LOPEZRUBIO, M
    KRSNIK, I
    CALERO, MA
    DELCAMPO, JF
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (04) : 313 - 313
12345